Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safinamide for PD-related chronic pain
NCT03841604Phase 4Completed
- Sponsor
- Zambon
- Start
- Apr 2019
- Primary completion
- Apr 2021
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 4 trial of safinamide in Parkinson's disease (PD), sponsored by Zambon. Started Apr 2019; status: completed.
02
Drugs
safinamide
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT03841604.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03841604.